| Literature DB >> 28120582 |
Jae Koo Lee1, Young Joon Rho1, Dong Mun Jeong1, Seung Chul Rhim2, Sang Joon Kim3.
Abstract
In this report, the patient was pre-diagnosed as meningioma before surgery, which turned out to be meningeal melanocytoma. Hence, we will discuss the interpretation of imaging and neurological statuses that may help avoid this problem. A 45-year-old man had increasing pain around the neck 14 months prior to admission. His cervical spine MR imaging revealed a space-occupying, contrast-enhancing mass within the dura at the level of C1. The neurologic examination revealed that the patient had left-sided lower extremity weakness of 4+, decreased sensation on the right side, and hyperreflexia in both legs. Department of Neuroradiology interpreted CT and MR imaging as meningiom. The patient underwent decompression and removal of the mass. We confirmed diagnosis as meningeal melanocytoma through pathologic findings. Afterwards, we reviewed the patient's imaging work-up, which showed typical findings of meningeal melanocytoma. However, it was mistaken as meningioma, since the disease is rare.Entities:
Keywords: Meningeal melanocytoma; melanoma; meningioma
Mesh:
Year: 2017 PMID: 28120582 PMCID: PMC5290031 DOI: 10.3349/ymj.2017.58.2.467
Source DB: PubMed Journal: Yonsei Med J ISSN: 0513-5796 Impact factor: 2.759
Fig. 1An approximately 3-cm T1 high signal intensity and T2 low signal intensity homogenous enhancing intradural extramedullary mass abutting the left posterolateral aspect of the dura at C1 level, without adjacent dural thickening or dural tail sign, no evidence of abnormal bone change. (A) Contrast CT axial image. (B) Contrast CT saggital image. (C) T1-enhanced image. (D) T2 sagittal image. (E) T1 enhanced sagittal image. (F) T1 sagittal image.
Fig. 2(A and B) Intraoperative microscopic findings. A black colored, well-circumscribed, nodular tumor was seen. The tumor was a soft mass and well capsulated.
Fig. 3The results of immunohistochemical staining. (A) Hematoxylin and eosin staining (×100). (B) HMB45 staining (×20). (C) S-100 protein staining (×20). (D) Ki-67 labeling index (<5%) (×100). Microscopic features supporting malignant melanoma, such as mitoses, necrosis, or nuclear pleomorphism were not observed, and the Ki-67 labeling index was low.